Elisabeth Kretschmer‐Chott

453 total citations
17 papers, 304 citations indexed

About

Elisabeth Kretschmer‐Chott is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Elisabeth Kretschmer‐Chott has authored 17 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Elisabeth Kretschmer‐Chott's work include Radiopharmaceutical Chemistry and Applications (6 papers), Prostate Cancer Treatment and Research (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Elisabeth Kretschmer‐Chott is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Prostate Cancer Treatment and Research (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Elisabeth Kretschmer‐Chott collaborates with scholars based in Austria, United States and Russia. Elisabeth Kretschmer‐Chott's co-authors include Markus Raderer, Markus Tiemann, Peter Herzog, Andreas Püspök, Wolfgang Fischbach, Manfred Stolte, Berthold Streubel, Gerhard Seitz, Christine Mannhalter and Andreas Chott and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Nuclear Medicine and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Elisabeth Kretschmer‐Chott

15 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Kretschmer‐Chott Austria 7 146 120 108 87 68 17 304
Ho Kyung Chun South Korea 9 119 0.8× 182 1.5× 44 0.4× 64 0.7× 62 0.9× 14 379
Ji Hyun Park South Korea 8 94 0.6× 123 1.0× 146 1.4× 26 0.3× 35 0.5× 22 307
Megan Greally Ireland 9 68 0.5× 231 1.9× 161 1.5× 37 0.4× 25 0.4× 41 399
Antoine Italiano France 7 41 0.3× 108 0.9× 127 1.2× 13 0.1× 45 0.7× 28 245
Michelle Leviov Israel 12 176 1.2× 101 0.8× 87 0.8× 23 0.3× 12 0.2× 26 329
R. Camisa Italy 9 64 0.4× 300 2.5× 219 2.0× 57 0.7× 45 0.7× 18 398
Mahsa Ahadi Australia 10 106 0.7× 238 2.0× 176 1.6× 24 0.3× 17 0.3× 26 445
Rambha Pandey India 10 54 0.4× 181 1.5× 160 1.5× 21 0.2× 15 0.2× 50 397
Gene Saylors United States 9 118 0.8× 241 2.0× 200 1.9× 44 0.5× 5 0.1× 14 426
John Theodorus Plukker Netherlands 11 77 0.5× 131 1.1× 161 1.5× 43 0.5× 22 0.3× 26 458

Countries citing papers authored by Elisabeth Kretschmer‐Chott

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Kretschmer‐Chott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Kretschmer‐Chott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Kretschmer‐Chott more than expected).

Fields of papers citing papers by Elisabeth Kretschmer‐Chott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Kretschmer‐Chott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Kretschmer‐Chott. The network helps show where Elisabeth Kretschmer‐Chott may publish in the future.

Co-authorship network of co-authors of Elisabeth Kretschmer‐Chott

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Kretschmer‐Chott. A scholar is included among the top collaborators of Elisabeth Kretschmer‐Chott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Kretschmer‐Chott. Elisabeth Kretschmer‐Chott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kretschmer‐Chott, Elisabeth, Gero Kramer, Philipp Ritt, et al.. (2025). Efficacy, Safety, Blood Kinetics, and 213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients. Journal of Nuclear Medicine. 66(8). 1239–1244.
2.
Mazal, Peter, et al.. (2024). From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms. Therapeutic Advances in Medical Oncology. 16. 12685052–12685052. 2 indexed citations
3.
Mazal, Peter, Elisabeth Kretschmer‐Chott, Alexander Haug, et al.. (2024). Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms. Endocrine Related Cancer. 31(3).
4.
Kraus, Teresa, et al.. (2024). Value of follow-up diagnostic radioiodine scans in differentiated thyroid cancer. Endocrine Connections. 13(5). 1 indexed citations
5.
Kiesewetter, Barbara, et al.. (2023). Does the dose matter? Antiproliferative efficacy and toxicity of everolimus in patients with neuroendocrine tumors – Experiences from a tertiary referral center. Journal of Neuroendocrinology. 35(8). e13319–e13319. 3 indexed citations
6.
Wollenweber, Tim, René Rettl, Elisabeth Kretschmer‐Chott, et al.. (2022). Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters. Journal of Nuclear Cardiology. 30(4). 1363–1371. 5 indexed citations
7.
Kiesewetter, Barbara, Peter Mazal, Elisabeth Kretschmer‐Chott, Marius E. Mayerhoefer, & Markus Raderer. (2022). Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice. ESMO Open. 7(3). 100478–100478. 8 indexed citations
8.
9.
Kretschmer‐Chott, Elisabeth, et al.. (2022). Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna. Therapeutic Advances in Medical Oncology. 14. 4287550421–4287550421. 1 indexed citations
10.
Oszwald, André, Tim Wollenweber, Elisabeth Kretschmer‐Chott, et al.. (2022). Response to [177Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastases. Nuclear Medicine Communications. 43(11). 1113–1120. 3 indexed citations
11.
Kiesewetter, Barbara, Philipp Riss, Christian Scheuba, et al.. (2021). Management of adrenocortical carcinoma: are we making progress?. Therapeutic Advances in Medical Oncology. 13. 4277450441–4277450441. 17 indexed citations
12.
Rasul, Sazan, Tim Wollenweber, Elisabeth Kretschmer‐Chott, et al.. (2021). Response and Toxicity to the Second Course of 3 Cycles of 177Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers. 13(10). 2489–2489. 5 indexed citations
13.
Wollenweber, Tim, Elisabeth Kretschmer‐Chott, Michael Weber, et al.. (2021). Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer. Current Oncology. 28(5). 3692–3704. 7 indexed citations
14.
Rasul, Sazan, Markus Hartenbach, Tim Wollenweber, et al.. (2020). Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(5). 1650–1657. 27 indexed citations
15.
Wollenweber, Tim, René Rettl, Elisabeth Kretschmer‐Chott, et al.. (2020). In Vivo Quantification of Myocardial Amyloid Deposits in Patients with Suspected Transthyretin-Related Amyloidosis (ATTR). Journal of Clinical Medicine. 9(11). 3446–3446. 23 indexed citations
16.
Rasul, Sazan, Marcus Hacker, Elisabeth Kretschmer‐Chott, et al.. (2019). Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks. European Journal of Nuclear Medicine and Molecular Imaging. 47(3). 713–720. 46 indexed citations
17.
Streubel, Berthold, Elisabeth Kretschmer‐Chott, Andreas Püspök, et al.. (2011). Primary Follicular Lymphoma of the Duodenum Is a Distinct Mucosal/Submucosal Variant of Follicular Lymphoma: A Retrospective Study of 63 Cases. Journal of Clinical Oncology. 29(11). 1445–1451. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ho Kyung Chun Breakdown of academic impact, for papers by Ji Hyun Park Breakdown of academic impact, for papers by Megan Greally Breakdown of academic impact, for papers by Antoine Italiano Breakdown of academic impact, for papers by Michelle Leviov Breakdown of academic impact, for papers by R. Camisa Breakdown of academic impact, for papers by Mahsa Ahadi Breakdown of academic impact, for papers by Rambha Pandey Breakdown of academic impact, for papers by Gene Saylors Breakdown of academic impact, for papers by John Theodorus Plukker
Rankless by CCL
2026